世界のαサラセミア治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Alpha Thalassemia Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-3782
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、98ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、αサラセミア治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（葉酸、デフェラシロクス、デフェリプロン、ヒドロキシ尿素）、用途別市場規模（病院、外来外科センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・αサラセミア治療の市場動向
・企業の競争状況、市場シェア
・αサラセミア治療の種類別市場規模と予測2016-2027（葉酸、デフェラシロクス、デフェリプロン、ヒドロキシ尿素）
・αサラセミア治療の用途別市場規模と予測2016-2027（病院、外来外科センター、その他）
・αサラセミア治療の北米市場規模2016-2027（アメリカ、カナダ）
・αサラセミア治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・αサラセミア治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・αサラセミア治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・αサラセミア治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（GlaxoSmithKline、Novartis AG、Bellicum Pharmaceuticals、Acceleron Pharma、Johnson & Johnson、Merck & Co.、Gilead Sciences, Inc.）
・結論

Alpha thalassemia causes due to deficiency or absence of alpha globin chains results in alpha thalassemia which is asymptomatic with general hematologic findings and gains silent carrier status.

Market Analysis and Insights: Global Alpha Thalassemia Treatment Market
The global Alpha Thalassemia Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Alpha Thalassemia Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Alpha Thalassemia Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Alpha Thalassemia Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Alpha Thalassemia Treatment market.

Global Alpha Thalassemia Treatment Scope and Market Size
Alpha Thalassemia Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Alpha Thalassemia Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Folic Acid
Deferasirox
Deferiprone
Hydroxyurea

Segment by Application
Hospitals
Ambulatory Surgical Centers
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
GlaxoSmithKline
Novartis AG
Bellicum Pharmaceuticals
Acceleron Pharma
Johnson & Johnson
Merck & Co.
Gilead Sciences, Inc.

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Alpha Thalassemia Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Folic Acid
1.2.3 Deferasirox
1.2.4 Deferiprone
1.2.5 Hydroxyurea
1.3 Market by Application
1.3.1 Global Alpha Thalassemia Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Alpha Thalassemia Treatment Market Perspective (2016-2027)
2.2 Alpha Thalassemia Treatment Growth Trends by Regions
2.2.1 Alpha Thalassemia Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Alpha Thalassemia Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Alpha Thalassemia Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Alpha Thalassemia Treatment Industry Dynamic
2.3.1 Alpha Thalassemia Treatment Market Trends
2.3.2 Alpha Thalassemia Treatment Market Drivers
2.3.3 Alpha Thalassemia Treatment Market Challenges
2.3.4 Alpha Thalassemia Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Alpha Thalassemia Treatment Players by Revenue
3.1.1 Global Top Alpha Thalassemia Treatment Players by Revenue (2016-2021)
3.1.2 Global Alpha Thalassemia Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Alpha Thalassemia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Alpha Thalassemia Treatment Revenue
3.4 Global Alpha Thalassemia Treatment Market Concentration Ratio
3.4.1 Global Alpha Thalassemia Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Alpha Thalassemia Treatment Revenue in 2020
3.5 Alpha Thalassemia Treatment Key Players Head office and Area Served
3.6 Key Players Alpha Thalassemia Treatment Product Solution and Service
3.7 Date of Enter into Alpha Thalassemia Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Alpha Thalassemia Treatment Breakdown Data by Type
4.1 Global Alpha Thalassemia Treatment Historic Market Size by Type (2016-2021)
4.2 Global Alpha Thalassemia Treatment Forecasted Market Size by Type (2022-2027)

5 Alpha Thalassemia Treatment Breakdown Data by Application
5.1 Global Alpha Thalassemia Treatment Historic Market Size by Application (2016-2021)
5.2 Global Alpha Thalassemia Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Alpha Thalassemia Treatment Market Size (2016-2027)
6.2 North America Alpha Thalassemia Treatment Market Size by Type
6.2.1 North America Alpha Thalassemia Treatment Market Size by Type (2016-2021)
6.2.2 North America Alpha Thalassemia Treatment Market Size by Type (2022-2027)
6.2.3 North America Alpha Thalassemia Treatment Market Size by Type (2016-2027)
6.3 North America Alpha Thalassemia Treatment Market Size by Application
6.3.1 North America Alpha Thalassemia Treatment Market Size by Application (2016-2021)
6.3.2 North America Alpha Thalassemia Treatment Market Size by Application (2022-2027)
6.3.3 North America Alpha Thalassemia Treatment Market Size by Application (2016-2027)
6.4 North America Alpha Thalassemia Treatment Market Size by Country
6.4.1 North America Alpha Thalassemia Treatment Market Size by Country (2016-2021)
6.4.2 North America Alpha Thalassemia Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Alpha Thalassemia Treatment Market Size (2016-2027)
7.2 Europe Alpha Thalassemia Treatment Market Size by Type
7.2.1 Europe Alpha Thalassemia Treatment Market Size by Type (2016-2021)
7.2.2 Europe Alpha Thalassemia Treatment Market Size by Type (2022-2027)
7.2.3 Europe Alpha Thalassemia Treatment Market Size by Type (2016-2027)
7.3 Europe Alpha Thalassemia Treatment Market Size by Application
7.3.1 Europe Alpha Thalassemia Treatment Market Size by Application (2016-2021)
7.3.2 Europe Alpha Thalassemia Treatment Market Size by Application (2022-2027)
7.3.3 Europe Alpha Thalassemia Treatment Market Size by Application (2016-2027)
7.4 Europe Alpha Thalassemia Treatment Market Size by Country
7.4.1 Europe Alpha Thalassemia Treatment Market Size by Country (2016-2021)
7.4.2 Europe Alpha Thalassemia Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Alpha Thalassemia Treatment Market Size (2016-2027)
8.2 Asia-Pacific Alpha Thalassemia Treatment Market Size by Type
8.2.1 Asia-Pacific Alpha Thalassemia Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Alpha Thalassemia Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Alpha Thalassemia Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Alpha Thalassemia Treatment Market Size by Application
8.3.1 Asia-Pacific Alpha Thalassemia Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Alpha Thalassemia Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Alpha Thalassemia Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Alpha Thalassemia Treatment Market Size by Region
8.4.1 Asia-Pacific Alpha Thalassemia Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Alpha Thalassemia Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Alpha Thalassemia Treatment Market Size (2016-2027)
9.2 Latin America Alpha Thalassemia Treatment Market Size by Type
9.2.1 Latin America Alpha Thalassemia Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Alpha Thalassemia Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Alpha Thalassemia Treatment Market Size by Type (2016-2027)
9.3 Latin America Alpha Thalassemia Treatment Market Size by Application
9.3.1 Latin America Alpha Thalassemia Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Alpha Thalassemia Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Alpha Thalassemia Treatment Market Size by Application (2016-2027)
9.4 Latin America Alpha Thalassemia Treatment Market Size by Country
9.4.1 Latin America Alpha Thalassemia Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Alpha Thalassemia Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Alpha Thalassemia Treatment Market Size (2016-2027)
10.2 Middle East & Africa Alpha Thalassemia Treatment Market Size by Type
10.2.1 Middle East & Africa Alpha Thalassemia Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Alpha Thalassemia Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Alpha Thalassemia Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Alpha Thalassemia Treatment Market Size by Application
10.3.1 Middle East & Africa Alpha Thalassemia Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Alpha Thalassemia Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Alpha Thalassemia Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Alpha Thalassemia Treatment Market Size by Country
10.4.1 Middle East & Africa Alpha Thalassemia Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Alpha Thalassemia Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Alpha Thalassemia Treatment Introduction
11.1.4 GlaxoSmithKline Revenue in Alpha Thalassemia Treatment Business (2016-2021)
11.1.5 GlaxoSmithKline Recent Development
11.2 Novartis AG
11.2.1 Novartis AG Company Details
11.2.2 Novartis AG Business Overview
11.2.3 Novartis AG Alpha Thalassemia Treatment Introduction
11.2.4 Novartis AG Revenue in Alpha Thalassemia Treatment Business (2016-2021)
11.2.5 Novartis AG Recent Development
11.3 Bellicum Pharmaceuticals
11.3.1 Bellicum Pharmaceuticals Company Details
11.3.2 Bellicum Pharmaceuticals Business Overview
11.3.3 Bellicum Pharmaceuticals Alpha Thalassemia Treatment Introduction
11.3.4 Bellicum Pharmaceuticals Revenue in Alpha Thalassemia Treatment Business (2016-2021)
11.3.5 Bellicum Pharmaceuticals Recent Development
11.4 Acceleron Pharma
11.4.1 Acceleron Pharma Company Details
11.4.2 Acceleron Pharma Business Overview
11.4.3 Acceleron Pharma Alpha Thalassemia Treatment Introduction
11.4.4 Acceleron Pharma Revenue in Alpha Thalassemia Treatment Business (2016-2021)
11.4.5 Acceleron Pharma Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Alpha Thalassemia Treatment Introduction
11.5.4 Johnson & Johnson Revenue in Alpha Thalassemia Treatment Business (2016-2021)
11.5.5 Johnson & Johnson Recent Development
11.6 Merck & Co.
11.6.1 Merck & Co. Company Details
11.6.2 Merck & Co. Business Overview
11.6.3 Merck & Co. Alpha Thalassemia Treatment Introduction
11.6.4 Merck & Co. Revenue in Alpha Thalassemia Treatment Business (2016-2021)
11.6.5 Merck & Co. Recent Development
11.7 Gilead Sciences, Inc.
11.7.1 Gilead Sciences, Inc. Company Details
11.7.2 Gilead Sciences, Inc. Business Overview
11.7.3 Gilead Sciences, Inc. Alpha Thalassemia Treatment Introduction
11.7.4 Gilead Sciences, Inc. Revenue in Alpha Thalassemia Treatment Business (2016-2021)
11.7.5 Gilead Sciences, Inc. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Alpha Thalassemia Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Folic Acid
Table 3. Key Players of Deferasirox
Table 4. Key Players of Deferiprone
Table 5. Key Players of Hydroxyurea
Table 6. Global Alpha Thalassemia Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Alpha Thalassemia Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Alpha Thalassemia Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Alpha Thalassemia Treatment Market Share by Regions (2016-2021)
Table 10. Global Alpha Thalassemia Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Alpha Thalassemia Treatment Market Share by Regions (2022-2027)
Table 12. Alpha Thalassemia Treatment Market Trends
Table 13. Alpha Thalassemia Treatment Market Drivers
Table 14. Alpha Thalassemia Treatment Market Challenges
Table 15. Alpha Thalassemia Treatment Market Restraints
Table 16. Global Alpha Thalassemia Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Alpha Thalassemia Treatment Market Share by Players (2016-2021)
Table 18. Global Top Alpha Thalassemia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alpha Thalassemia Treatment as of 2020)
Table 19. Ranking of Global Top Alpha Thalassemia Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Alpha Thalassemia Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Alpha Thalassemia Treatment Product Solution and Service
Table 23. Date of Enter into Alpha Thalassemia Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Alpha Thalassemia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Alpha Thalassemia Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Alpha Thalassemia Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Alpha Thalassemia Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Alpha Thalassemia Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Alpha Thalassemia Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Alpha Thalassemia Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Alpha Thalassemia Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Alpha Thalassemia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Alpha Thalassemia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Alpha Thalassemia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Alpha Thalassemia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Alpha Thalassemia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Alpha Thalassemia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Alpha Thalassemia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Alpha Thalassemia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Alpha Thalassemia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Alpha Thalassemia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Alpha Thalassemia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Alpha Thalassemia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Alpha Thalassemia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Alpha Thalassemia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Alpha Thalassemia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Alpha Thalassemia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Alpha Thalassemia Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Alpha Thalassemia Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Alpha Thalassemia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Alpha Thalassemia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Alpha Thalassemia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Alpha Thalassemia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Alpha Thalassemia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Alpha Thalassemia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Alpha Thalassemia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Alpha Thalassemia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Alpha Thalassemia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Alpha Thalassemia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Alpha Thalassemia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Alpha Thalassemia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. GlaxoSmithKline Company Details
Table 64. GlaxoSmithKline Business Overview
Table 65. GlaxoSmithKline Alpha Thalassemia Treatment Product
Table 66. GlaxoSmithKline Revenue in Alpha Thalassemia Treatment Business (2016-2021) & (US$ Million)
Table 67. GlaxoSmithKline Recent Development
Table 68. Novartis AG Company Details
Table 69. Novartis AG Business Overview
Table 70. Novartis AG Alpha Thalassemia Treatment Product
Table 71. Novartis AG Revenue in Alpha Thalassemia Treatment Business (2016-2021) & (US$ Million)
Table 72. Novartis AG Recent Development
Table 73. Bellicum Pharmaceuticals Company Details
Table 74. Bellicum Pharmaceuticals Business Overview
Table 75. Bellicum Pharmaceuticals Alpha Thalassemia Treatment Product
Table 76. Bellicum Pharmaceuticals Revenue in Alpha Thalassemia Treatment Business (2016-2021) & (US$ Million)
Table 77. Bellicum Pharmaceuticals Recent Development
Table 78. Acceleron Pharma Company Details
Table 79. Acceleron Pharma Business Overview
Table 80. Acceleron Pharma Alpha Thalassemia Treatment Product
Table 81. Acceleron Pharma Revenue in Alpha Thalassemia Treatment Business (2016-2021) & (US$ Million)
Table 82. Acceleron Pharma Recent Development
Table 83. Johnson & Johnson Company Details
Table 84. Johnson & Johnson Business Overview
Table 85. Johnson & Johnson Alpha Thalassemia Treatment Product
Table 86. Johnson & Johnson Revenue in Alpha Thalassemia Treatment Business (2016-2021) & (US$ Million)
Table 87. Johnson & Johnson Recent Development
Table 88. Merck & Co. Company Details
Table 89. Merck & Co. Business Overview
Table 90. Merck & Co. Alpha Thalassemia Treatment Product
Table 91. Merck & Co. Revenue in Alpha Thalassemia Treatment Business (2016-2021) & (US$ Million)
Table 92. Merck & Co. Recent Development
Table 93. Gilead Sciences, Inc. Company Details
Table 94. Gilead Sciences, Inc. Business Overview
Table 95. Gilead Sciences, Inc. Alpha Thalassemia Treatment Product
Table 96. Gilead Sciences, Inc. Revenue in Alpha Thalassemia Treatment Business (2016-2021) & (US$ Million)
Table 97. Gilead Sciences, Inc. Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Alpha Thalassemia Treatment Market Share by Type: 2020 VS 2027
Figure 2. Folic Acid Features
Figure 3. Deferasirox Features
Figure 4. Deferiprone Features
Figure 5. Hydroxyurea Features
Figure 6. Global Alpha Thalassemia Treatment Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Ambulatory Surgical Centers Case Studies
Figure 9. Others Case Studies
Figure 10. Alpha Thalassemia Treatment Report Years Considered
Figure 11. Global Alpha Thalassemia Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Alpha Thalassemia Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Alpha Thalassemia Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Alpha Thalassemia Treatment Market Share by Regions (2022-2027)
Figure 15. Global Alpha Thalassemia Treatment Market Share by Players in 2020
Figure 16. Global Top Alpha Thalassemia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alpha Thalassemia Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Alpha Thalassemia Treatment Revenue in 2020
Figure 18. Global Alpha Thalassemia Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Alpha Thalassemia Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Alpha Thalassemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Alpha Thalassemia Treatment Market Share by Type (2016-2027)
Figure 22. North America Alpha Thalassemia Treatment Market Share by Application (2016-2027)
Figure 23. North America Alpha Thalassemia Treatment Market Share by Country (2016-2027)
Figure 24. United States Alpha Thalassemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Alpha Thalassemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Alpha Thalassemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Alpha Thalassemia Treatment Market Share by Type (2016-2027)
Figure 28. Europe Alpha Thalassemia Treatment Market Share by Application (2016-2027)
Figure 29. Europe Alpha Thalassemia Treatment Market Share by Country (2016-2027)
Figure 30. Germany Alpha Thalassemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Alpha Thalassemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Alpha Thalassemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Alpha Thalassemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Alpha Thalassemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Alpha Thalassemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Alpha Thalassemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Alpha Thalassemia Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Alpha Thalassemia Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Alpha Thalassemia Treatment Market Share by Region (2016-2027)
Figure 40. China Alpha Thalassemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Alpha Thalassemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Alpha Thalassemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Alpha Thalassemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Alpha Thalassemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Alpha Thalassemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Alpha Thalassemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Alpha Thalassemia Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Alpha Thalassemia Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Alpha Thalassemia Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Alpha Thalassemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Alpha Thalassemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Alpha Thalassemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Alpha Thalassemia Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Alpha Thalassemia Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Alpha Thalassemia Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Alpha Thalassemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Alpha Thalassemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Alpha Thalassemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. GlaxoSmithKline Revenue Growth Rate in Alpha Thalassemia Treatment Business (2016-2021)
Figure 60. Novartis AG Revenue Growth Rate in Alpha Thalassemia Treatment Business (2016-2021)
Figure 61. Bellicum Pharmaceuticals Revenue Growth Rate in Alpha Thalassemia Treatment Business (2016-2021)
Figure 62. Acceleron Pharma Revenue Growth Rate in Alpha Thalassemia Treatment Business (2016-2021)
Figure 63. Johnson & Johnson Revenue Growth Rate in Alpha Thalassemia Treatment Business (2016-2021)
Figure 64. Merck & Co. Revenue Growth Rate in Alpha Thalassemia Treatment Business (2016-2021)
Figure 65. Gilead Sciences, Inc. Revenue Growth Rate in Alpha Thalassemia Treatment Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

以下、関連資料のご紹介

世界のサラセミア遺伝子検出市場規模・現状・予測（2021年-2027年）

Global Thalassemia Gene Detection Market Size, Status and Forecast 2021-2027
QFJ1-4949 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、サラセミア遺伝子検出の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（遺伝子スクリーニング、生殖遺伝子検査、診断検査、遺伝子保因者検査、発症前検査）、用途別市場規模（病院、クリニック、診断センター）、主...

世界のβ-サラセミア検査市場規模・現状・予測（2021年-2027年）

Global Beta Thalassemia Testing Market Size, Status and Forecast 2021-2027
QFJ1-3896 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、β-サラセミア検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（キット、消耗品）、用途別市場規模（病院＆専門クリニック、診断センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本...

世界のα2Cアドレナリン受容体市場規模・現状・予測（2021年-2027年）

Global Alpha 2C Adrenergic Receptor Market Size, Status and Forecast 2021-2027
QFJ1-5572 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、α2Cアドレナリン受容体の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ラクリペップ、JNJ-4789、SKL-PSY、その他）、用途別市場規模（双極性障害、ドライアイ、大うつ病、その他）、主要地域別...

世界のα1アンチトリプシン欠乏症増強療法市場規模・現状・予測（2021年-2027年）

Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size, Status and Forecast 2021-2027
QFJ1-3783 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、α1アンチトリプシン欠乏症増強療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（グラシア、アララストNP、プロラスチンC、その他）、用途別市場規模（病院、専門診療所）、主要地域別市場規模（北米、アメ...

世界のインテグリンアルファV市場規模・現状・予測（2021年-2027年）

Global Integrin Alpha V Market Size, Status and Forecast 2021-2027
QFJ1-5804 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、インテグリンアルファVの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（MK-0429、C-16Y、264-RAD、AC-301、その他）、用途別市場規模（代謝性疾患、眼科、呼吸器、感染症、その他）、主...

世界のヘモグロビン症治療市場規模・現状・予測（2021年-2027年）

Global Hemoglobinopathy Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5774 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、ヘモグロビン症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ヒドロキシウレア、グルタミン、ジンテグロ、その他）、用途別市場規模（鎌状赤血球症、サラセミア）、主要地域別市場規模（北米、アメリカ、欧...

世界の熱帯性痙性対麻痺治療市場規模・現状・予測（2021年-2027年）

Global Tropical Spastic Paraparesis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4985 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、熱帯性痙性対麻痺治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（17-アルファ-エチニルテストステロン、モガムリズマブ、その他）、用途別市場規模（病院、クリニック、外科医院、その他）、主要地域別市...

世界の貧血治療薬市場規模・現状・予測（2021年-2027年）

Global Anemia Treatment Drugs Market Size, Status and Forecast 2021-2027
QFJ1-3805 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、貧血治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（サプリメント、抗生物質、免疫抑制剤、骨髄刺激剤、コルチコステロイド、遺伝子治療、鉄キレート剤）、用途別市場規模（鉄欠乏性貧血、サラセミア、再生...

世界の未分化甲状腺がん治療市場規模・現状・予測（2021年-2027年）

Global Anaplastic Thyroid Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3803 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、未分化甲状腺がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

世界の総胆管結石症治療市場規模・現状・予測（2021年-2027年）

Global Choledocholithiasis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4004 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、総胆管結石症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（薬物治療、外科的治療）、用途別市場規模（病院、専門クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓...

世界のサラセミア遺伝子検出市場規模・現状・予測（2021年-2027年） A method for detecting and diagnosing thalassemia Market Analysis and Insights: Global Thalassemia Gene Detection Market The global Thalassemia Gene Detection market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-stand…
世界のβ-サラセミア検査市場規模・現状・予測（2021年-2027年） Beta thalassemia is a condition in which the production of hemoglobin reduces. Hemoglobin is the iron-containing protein in red blood cells that carries oxygen to cells throughout the body. Risk factors associated with thalassemia are family history and ancestry. The types of beta thalassemia depend…
世界のα2Cアドレナリン受容体市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Alpha 2C Adrenergic Receptor Market The global Alpha 2C Adrenergic Receptor market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integri…
世界のα1アンチトリプシン欠乏症増強療法市場規模・現状・予測（2021年-2027年） Alpha-1 antitrypsin deficiency (AATD) is an inherited condition characterized as a low or unpredictable level of alpha-1 protein, generated by liver. The disease most commonly affects lungs and liver and is often undiagnosed. Augmentation therapy is the most specific therapy for the treatment of AAT…
チオクト酸（アルファリポ酸）（ALA）のグローバル市場2021 Lipoic acid is a vitamin-like compound found in a slightly yellow crystalline powder form. It can be synthetically produced in laboratories for medical use, but is found naturally in abundance in foods such as yeast, liver, kidney, broccoli, spinach and potatoes. Lipoic Acid can be divided into α- L…